TrialBlood advances2025

Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update.

Eva Kimby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.